Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 243,197 | 446,658 | 389,115 | 355,663 | 213,171 |
| Marketable Securities | 788,214 | 838,255 | 442,986 | 105,208 | 491,455 |
| Receivables | 12,529 | 9,601 | 23,489 | 31,320 | 62,923 |
| TOTAL | $1,057,039 | $1,307,026 | $867,581 | $496,851 | $771,406 |
| Non-Current Assets | |||||
| PPE Net | 72,333 | 62,279 | 68,331 | 66,509 | 61,535 |
| Investments And Advances | 0 | 0 | 0 | 6,925 | 57,126 |
| Intangibles | 544,802 | 544,802 | 0 | 0 | 0 |
| Other Non-Current Assets | 51,272 | 41,381 | 44,567 | 31,192 | 31,512 |
| TOTAL | $668,407 | $648,462 | $112,898 | $104,626 | $150,173 |
| Total Assets | $1,725,446 | $1,955,488 | $980,479 | $601,477 | $921,579 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 136,991 | 32,071 | N/A | 19,997 | 101,750 |
| Accounts payable and accrued liabilities | 35,851 | 36,989 | 51,760 | 32,750 | 15,368 |
| Accrued Expenses | 143,373 | 125,640 | 105,871 | 103,956 | 97,999 |
| Other current liabilities | 83,949 | 15,227 | 21,255 | 17,048 | 2,008 |
| TOTAL | $474,783 | $284,883 | $216,564 | $199,279 | $251,014 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 121,765 | N/A | N/A | 19,997 |
| Deferred Revenues | 74,619 | 74,956 | 37,678 | 25,528 | 33,889 |
| Other Non-Current Liabilities | 426,363 | 66,641 | 315,245 | 29,686 | 28,338 |
| TOTAL | $746,690 | $574,259 | $525,041 | $130,903 | $164,630 |
| Total Liabilities | $1,221,473 | $859,142 | $741,605 | $330,182 | $415,644 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 204,413 | 200,576 | 152,190 | 132,965 | 126,651 |
| Common Shares | 2,016 | 1,982 | 1,494 | 1,312 | 1,244 |
| Retained earnings | -3,444,409 | -2,689,783 | -2,047,605 | -1,587,754 | -1,196,475 |
| Other shareholders' equity | -1,067 | -640 | 3,168 | 881 | -962 |
| TOTAL | $503,973 | $1,096,346 | $238,874 | $271,295 | $505,935 |
| Total Liabilities And Equity | $1,725,446 | $1,955,488 | $980,479 | $601,477 | $921,579 |